Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease

Recruiting now · Not applicable

Conditions studied: Inflamatory Bowel Disease

In brief

In this study the intestinal microbiome and metabolic profiles of patients with inflammatory bowel disease will be determined upon probiotic intervention.

Key facts

Study ID

NCT07533890

Run by

Insel Gruppe AG, University Hospital Bern

People needed

40

Starts

2026-05-01

Expected to finish

2028-12-01

Last updated by the study team

2026-06-30

Who can join

Age: 5 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent
• Diagnosis of inflammatory bowel disease according to actual guidelines (Porto Criteria)
• General good health
• Ability to understand and follow study procedures and understand informed consent
• Age 5 -18 years
• No probiotic therapy 4 weeks before entering into the study.

You may not qualify if…

• Participation in other clinical studies interfering with study procedures.
• Inability or contraindications to undergo the investigated intervention
• Severe or acute flare of disease (for UC PUCAI score ≥35, for CD wPCDAI >40)
• Treatment escalation within last 4 weeks for uncontrolled disease.
• Antibiotic or probiotic therapy within the last 4 weeks.

Where it is running

• Inselspital, Universitätsspital Bern Kinderklinik — Bern, Switzerland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.